Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET.
about
The pharmacology of neurokinin receptors in addiction: prospects for therapySimulation of PET scan timings for receptor occupancy studies of CNS drugs: a simple fixed-time design performed as well as scattered time point designs.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@en
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@nl
type
label
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@en
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@nl
prefLabel
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@en
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@nl
P2093
P2860
P50
P356
P1476
Characterising the plasma-targ ...... ntagonist GSK1144814 with PET.
@en
P2093
Clare Burgess
Emiliangelo Ratti
Eugenii A Rabiner
Frank A Gray
Graham E Searle
Italo Poggesi
Jan Passchier
Jonathan N Bullman
Julien Barletta
Khanum Ridler
P2860
P304
P356
10.1177/0269881113517953
P407
P577
2014-01-15T00:00:00Z